HOUSTON, Tex.--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTCBB: PWRM, https://www.power3medical.com), a leading proteomics company specializing in the development and commercialization of diagnostic tests for the early detection of breast cancer and neurodegenerative diseases, was recently spotlighted in several prominent local, national, and international news outlets.
